Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian Tumors

This publication has 40 references indexed in Scilit:

• Cancer statistics, 1998
  CA: A Cancer Journal for Clinicians, 1998
• p53 is a persistent and predictive marker in advanced ovarian carcinomas: multivariate analysis including comparison with Ki67 immunoreactivity
  Zeitschrift für Krebsforschung und Klinische Onkologie, 1997
• Reduced Expression of Cyclin–dependent Kinase Inhibitor p27^Kipl Is Associated with Advanced Stage and Invasiveness of Gastric Carcinomas
  Japanese Journal of Cancer Research, 1997
• TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas
  The Journal of Pathology, 1997
• Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27
  Science, 1995
• A Phase I Trial of Cyclosphosphamide and Carboplatinum Combined with Interleukin-3 in Women with Advanced-Stage Ovarian Cancer
  Gynecologic Oncology, 1995
• Ki67 Antigen Immunostaining (MIB 1 Monoclonal Antibody) in Serous Ovarian Tumors: Index of Proliferative Activity with Prognostic Significance
  Gynecologic Oncology, 1995
• p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
  Published by Elsevier ,1994
• p53 Expression in Epithelial Ovarian Neoplasms: Relationship to Clinical and Pathological Parameters, Ki-67 Expression and Flow Cytometry
  Gynecologic Oncology, 1994
• Advanced ovarian cancer: Three-year results of a 6–8 month, 2-drug cisplatin-containing regimen
  European Journal of Cancer and Clinical Oncology, 1987